Clopidogrel monotherapy versus aspirin monotherapy in patients with established cardiovascular disease: systematic review and meta-analysis

PT Tasoudis, IG Kyriakoulis, D Sagris… - Thrombosis and …, 2022 - thieme-connect.com
Background There is no clear consensus on whether aspirin offers better outcomes in terms
of secondary cardiovascular disease prevention compared with clopidogrel. Objective The …
被引用次数：4 相关文章

Clopidogrel Monotherapy versus Aspirin Monotherapy in Patients with Established Cardiovascular Disease: Systematic Review and Meta-Analysis

PT Tasoudis, IG Kyriakoulis, D Sagris, HC Diener… - 2022 - ir.lib.uth.gr
Background There is no clear consensus on whether aspirin offers better outcomes in terms
of secondary cardiovascular disease prevention compared with clopidogrel. Objective The …

Clopidogrel Monotherapy versus Aspirin Monotherapy in Patients with Established Cardiovascular Disease: Systematic Review and Meta-Analysis.

PT Tasoudis, IG Kyriakoulis, D Sagris… - Thrombosis and …, 2022 - europepmc.org
Background There is no clear consensus on whether aspirin offers better outcomes in terms
of secondary cardiovascular disease prevention compared with clopidogrel. Objective The …

Clopidogrel Monotherapy versus Aspirin Monotherapy in Patients with Established Cardiovascular Disease: Systematic Review and Meta-Analysis

PT Tasoudis, IG Kyriakoulis, D Sagris… - Thrombosis and …, 2022 - thieme-connect.com
Background There is no clear consensus on whether aspirin offers better outcomes in terms
of secondary cardiovascular disease prevention compared with clopidogrel. Objective The …

Clopidogrel Monotherapy versus Aspirin Monotherapy in Patients with Established Cardiovascular Disease: Systematic Review and Meta-Analysis

PT Tasoudis, IG Kyriakoulis… - Thrombosis and …, 2022 - pubmed.ncbi.nlm.nih.gov
Background There is no clear consensus on whether aspirin offers better outcomes in terms
of secondary cardiovascular disease prevention compared with clopidogrel. Objective The …